CALCIFORTE 500 mg, oral solution in an ampoule sweetened with sodium cyclamate and with sodium saccharin 30 ampoules of 10 ml
Active ingredients: Calcium D-glycero-D-gulo-heptonate, CALCIUM (LACTATE DE) PENTAHYDRATÉ, Calcium chloride, Calcium gluconate monohydrate, Saccharomyces cerevisiae
Commercialized according to BDPM
Oral solution30 ampoules of 10 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CALCIFORTE 500 mg, solution buvable en ampoule édulcorée au cyclamate de sodium et à la saccharine sodique
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 30 ampoule(s) en verre jaune(brun) de 10 ml
- Marketing authorisation holder
- GRIMBERG
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 14 Apr 2023
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65630160CIP73329829CIP133400933298296Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORURE DE CALCIUM DIHYDRATÉsolution | 0,5440 g · une ampoule de 10 ml | SA |
| GLUCONATE DE CALCIUMsolution | 1,0500 g · une ampoule de 10 ml | SA |
| CALCIUM (GLUCOHEPTONATE DE)solution | 0,9300 g · une ampoule de 10 ml | SA |
| SACCHAROMYCES CEREVISIAEsolution | 0,0300 g · une ampoule de 10 ml | SA |
| CALCIUM (LACTATE DE) PENTAHYDRATÉsolution | 1,2800 g · une ampoule de 10 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.